Predictive value of angiogenic proteins in patients with metastatic melanoma treated with bevacizumab monotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Predictive value of angiogenic proteins in patients with metastatic melanoma treated with bevacizumab monotherapy

Published:2018-11-09 Issue:1 Volume:5 Page:53-62
ISSN:2056-4538
Container-title:The Journal of Pathology: Clinical Research
language:en
Short-container-title:J Pathol Clin Res;

Author:

Schuster Cornelia¹²^ORCID,Akslen Lars A¹³,Stokowy Tomasz⁴⁵,Straume Oddbjørn¹²

Affiliation:

1. Centre for Cancer Biomarkers CCBIO, Department of Clinical Medicine; University of Bergen; Bergen Norway

2. Department of Oncology and Medical Physics; Haukeland University Hospital; Bergen Norway

3. Department of Pathology; Haukeland University Hospital; Bergen Norway

4. Department of Clinical Science; University of Bergen; Bergen Norway

5. Computational Biology Unit, Department of Informatics; University of Bergen; Bergen Norway

Funder

Universitetet i Bergen

Norges Forskningsråd

Helse Vest Research Fund

Kreftforeningen

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cjp2.116/fullpdf

Reference52 articles.

1. BRAF and MEK inhibition for the treatment of advanced BRAF mutant melanoma;Richman;Expert Opin Pharmacother,2015

2. Nivolumab in melanoma: latest evidence and clinical potential;Johnson;Ther Adv Med Oncol,2015

3. Pooled analysis of long-term survival data from phase II and phase III trials of Ipilimumab in Unresectable or metastatic melanoma;Schadendorf;J Clin Oncol,2015

4. Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab;Topalian;J Clin Oncol,2014

5. Combined Nivolumab and Ipilimumab or Monotherapy in untreated melanoma;Larkin;N Engl J Med,2015

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. uPAR+ extracellular vesicles: a robust biomarker of resistance to checkpoint inhibitor immunotherapy in metastatic melanoma patients;Journal for ImmunoTherapy of Cancer;2021-05

2. Alternative Vascularization Mechanisms in Tumor Resistance to Therapy;Cancers;2021-04-15

3. Activin A: an emerging target for improving cancer treatment?;Expert Opinion on Therapeutic Targets;2020-08-06

4. Activin A triggers angiogenesis via regulation of VEGFA and its overexpression is associated with poor prognosis of oral squamous cell carcinoma;International Journal of Oncology;2020-05-04

5. Whole genome and biomarker analysis of patients with recurrent glioblastoma on bevacizumab: A subset analysis of the CABARET trial;Journal of Clinical Neuroscience;2019-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3